MedPath

Bromday

These highlights do not include all the information needed to use Bromday™ (bromfenac ophthalmic solution) 0.09% safely and effectively. See full prescribing information for Bromday. Bromday  (bromfenac ophthalmic solution) 0.09% Initial U.S. Approval: 1997

Approved
Approval ID

234a2447-90a7-4b8a-a344-7eef1e5daa6a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 14, 2010

Manufacturers
FDA

Unit Dose Services

DUNS: 831995316

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

bromfenac

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50436-6301
Application NumberNDA021664
Product Classification
M
Marketing Category
C73594
G
Generic Name
bromfenac
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateJune 26, 2012
FDA Product Classification

INGREDIENTS (10)

BENZALKONIUM CHLORIDEInactive
Quantity: 0.05 mg in 1 mL
Code: F5UM2KM3W7
Classification: IACT
BROMFENAC SODIUMActive
Quantity: 0.9 mg in 1 mL
Code: 8ECV571Y37
Classification: ACTIM
BORIC ACIDInactive
Code: R57ZHV85D4
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
POVIDONESInactive
Code: FZ989GH94E
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SODIUM SULFITEInactive
Code: VTK01UQK3G
Classification: IACT
SODIUM BORATEInactive
Code: 91MBZ8H3QO
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Bromday - FDA Drug Approval Details